Immunity to the α(1, 3)Galactosyl epitope provides protection in mice challenged with colon cancer cells expressing α(1, 3)galactosyl-transferase: A novel suicide gene for cancer gene therapy

Cancer Research

Volumn 63, Issue 5, 2003, Pages 987-993

  Unfer, Robert C ^a,b   Heilrung, Daniel ^a,b   Link, Charles J ^a,b  

^a IOWA METHODIST MEDICAL CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSE; ALPHA 1,3 GALACTOSYLTRANSFERASE; EPITOPE; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL MEDIATED CYTOTOXICITY; COLON CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GRAFT REJECTION; IMMUNE SYSTEM; IMMUNITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; TUMOR CELL DESTRUCTION;

ANIMALS; ANTIBODIES, NEOPLASM; COLONIC NEOPLASMS; EPITOPES; GALACTOSYLTRANSFERASES; GENE THERAPY; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0037373881     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Link, C. J., Jr., Moorman. D., Seregina, T., Levy, J. P., and Schabold, K. J. A Phase 1 trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer. Hum. Gene Ther., 7: 1161-1179, 1996
2. Merritt, J. A., Roth, J. A., and Logothetis, C. J. Clinical evaluation of adenoviral-mediated p53 gene transfer: review of 1NGN 201 studies. Semin. Oncol. 28 (5 Suppl. 16): 105-114, 2001
3. Zwiebel, J. A., Nagler, C., Smiley, J. K., and Cheson, B. D. Clinical trials referral resource. Clinical trials of adenovirus-p53 gene therapy, Oncology (Huntingt.), 12: 1172-1175, 1998
4. Jemal. A., Thomas, A., Murray, T., and Thun, M. Cancer statistics 2002. CA - Cancer J. Clin., 52: 23-47, 2002
5. Galili, U., and Swanson, K. Gene sequences suggest inactivation of α1-3 galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc. Natl. Acad. Sci. USA, 88: 7401-7404, 1991
6. Galili, U., Mandrell, R. E., Hamedeh, R. M., Shohet, S. B., and Griffiss, J. M. Interaction between natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Immun. Infect., 56: 1730-1737, 1988
7. Hamadeh, R. M., Jarvis, G. A., Galili, U., Mandrell, R. E., Zhou, P., and Griffiss, J. M. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Investig., 89: 1223-1235, 1992
8. Galili, U., Anaraki, F., Thall, A., Hill-Black, C., and Radic, M. One percent of human circulating B-lymphocytes are capable of producing the natural anti-Gal antibody. Blood, 82: 2485-2493, 1993
9. Good, A. H., Cooper, D. K., Malcolm, A. J., Ippolito R. M., Koren, E., Neethling, F. A., Ye, Y., Zuhdi, N., and Lamontagne, L. R. Identification of the carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc., 24: 559-565, 1992
10. Cooper, D. K., Good, A. H., Koren, E., Koren, E., Oriol, R., Malcolm, A. J., Ippolito, R. M., Neethling, F. A., Ye, Y., Romano, E., and Zuhdi, N. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in humans. Transp. Immunol., 1: 198-205, 1993
11. Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., and McKenzie, I. F. Anti-pig IgM antibodies in human serum react predominantly with Galα(1.3)Gal epitopes. Proc. Natl. Acad. Sci. USA, 90: 11391-11395, 1993
12. Sandrin, M. S., and McKenzie, I. F. Galα(, 3)Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol. Rev., 141: 169-190, 1994
13. Vaughan, H. A., Loveland, B. E., and Sandrin, M. S. Galα(1, 3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation (Baltimore), 58: 879-882, 1994
14. Short, M. P., Choi, B. C., Lee, J. K., Malick, A., Birks, C. W., Setter, E., Sandrin, M. S., Squinto, S. P., and Rollins, S. A. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res., 27: 427-439, 1990
15. Kato, K., Yoshida, J., Mizuno, M., Sugita, K., and Emi, N. Retroviral transfer of herpes simplex thymidine kinase gene into glioma cells causes targeting of Ganciclovir cytotoxic effect. Neurol. Med. Chir. (Tokyo), 34: 339-344, 1994
16. Welsh, R. M., Jr., Cooper, N. R., Jensen, F. C., and Oldstone, M. B. Human serum lyses RNA tumour viruses. Nature (Lond.), 257: 612-614, 1975
17. Rother, R. P., Fodor, W. L., Springhom, J. P., Birks, C. W., Setter, E., Sandrin, M. S., Squinto, S. P., and Rollins, S. A. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med., 182: 1345-1355, 1995
18. Takeuchi, Y., Porter, C. D., Strahan, K. M., Preece, A. F., Gustafsson, K., Cosset, F. L., Weiss, R. A., and Collins, M. K. Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase. Nature (Lond.), 379: 85-88, 1996
19. Rollins, S. A., Birks, C. W., Setter, E., Squinto, S. P., and Rother, R. P. Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response. Hum. Gene Ther., 7: 619-626, 1996
20. Link, C. J., Levy, J. P., Seregina, T., Atchison, R., and Moorman, D. Protection of complement mediated lysis of murine vector producer cells by sCR1 and low molecular weight heparin. In: H. Mazarakis and S.J. Swart (eds.), Cancer Gene Therapy, pp. 135-152. London: IBC Library Series, 1997
21. Collins, M. K., Takeuchi, Y., Cosset, F. L., Tailor, C., and Weiss, R. A. Cold Spring Harbor Meeting: Gene Therapy. Cold Spring Harbor, N. Y., p. 97, 1994
22. Link, C. J., Jr., Seregina, T., Atchison, R., Hall, A., Muldoon, R., and Levy, J. Eliciting hyperacute xenograft response to treat human cancer: α(1.3) galactosyltransferase gene therapy. Anticancer Res., 18: 2301-2308, 1998
23. Thall, A. D., Maly, P., and Lowe, J. B. Oocyte Gaalα1, 3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem., 270: 21437-21440, 1995
24. Tearle, R. G., Tange, M. J., Zannetino, Z. L., Katerelos, M., Sinkel, T. A., Van Denderen, B. L., Lonie, A. J., Lyons, I., Nottle, M. B., Cox, T., Becker, C., Peura, A. M., Wigley, P. L., Crawford, R. J., Robins, A. J., Pearse, M. J., and d’Apice, A. J. The α-1.3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation (Baltimore), 61: 13-19, 1996
25. Thall, A. D., Murphy, H. S., and Lowe, J. B. α1, 3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant. Proc., 28: 556-557, 1996
26. Salvaris, E., Gock, H., Han. W., Murray-Segal, L., Barlow, H., Mottram, P., Pearse, M., Cowan, P., Goodman, D., and d’Apice, A. J. Naturally acquired anti-α Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Xenotransplantation. 7: 42-47, 2000
27. LaTemple, D. C., and Galili, U. Adult and neonatal anti-Gal response in knock-out mice for α1, 3galactosyltransferase. Xenotransplantation, 5: 191-196, 1998
28. Eckhardt, A. E., and Goldstein, I. J. Isolation and characterization of a family of α-D-galactosyl-containing glycopeptides from Ehrlich ascites tumor cells. Biochemistry. 22: 5290-5297, 1983
29. Spiro, D. G., and Bhoyroo, V. D. Occurrence of α-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. J. Biol. Chem., 259: 9858-9866, 1984
30. Rose, A. G., Cooper, D. K. C., Human, P. A., Reichenspurner, H., and Reichart, B. Histopathology of hyperacute rejection of the heart: experimental and clinical observation in allografts and xenografts. J. Heart Lung Transplant., 10: 223-234, 1991
31. Lai, L., Kolber-Simonds, D., Park, K. W., Cheong, H. T., Greenstein, J. L., Im, G. S., Samuel, M., Bonk, A., Rieke, A., Day, B. N., Murphy, C. N., Carter, D. B., Hawley, R. J., and Prather, R. S. Production of α-1-3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science (Wash. DC), 295: 1089-1092, 2002
32. Galili, U., Macher, B. A., Buehler, J., and Shohet, S. B. Human natural anti-α-galactosyl IgG. II. The specific recognition of α (1, 3)-linked galactose residues. J. Exp. Med., 162: 573-582, 1985
33. McMorrow, I. M., Comrack, C. A., Sachs, D. H., and DerSimonian, H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(α1, 3)Galactose epitope. Transplantation (Baltimore), 64: 501-510, 1997
34. LaTemple, D. C., Abrams, J. T., Zhang, S. Y., and Galili, U. Increased immunogenicity of tumor vaccines complexed with anti-Gal: Studies in knockout mice for α1, 3galactosyltransferase. Cancer Res., 59: 3417-3423, 1999
35. Maxwell-Armstrong, C. A., Durrant, L. G., and Scholefield, J. H. Colorectal cancer vaccines. Br. J. Surg., 85: 149-154, 1998
36. Miyagi, Y., Imai, N., Sasatomi, T., Yamada, A., Mine, T., Katagiri, K., Nakagawa, M., Muto, A., Okouchi, S., Isomoto, H., Shirouzu, K., Yamana, H., and Itoh, K. Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides. Clin. Cancer Res., 7: 3950-3962, 2001
37. Maruyama, S., Cantu, E., III, Galili, U., D’Agati, V., Godman, G., Stern, D. M., and Andres, G. α-Galactosyl epitopes on glycoproteins of porcine renal extracellular matrix. Kidney Int., 57: 655-663, 2000
38. Vaughan, H. A., McKenzie, I. F., and Sandrin, M. S. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the Galactose α(1-3)Galactose reactive lectin. Transplantation (Baltimore), 59: 102-109, 1995